Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOROX CO /DE/CLX · Entity 3474 | Director | December 31, 2025 | January 05, 2026 |
| METLIFE INCMET · Entity 488 | EVP - Gl. Chief Marketing Off. | June 14, 2021 | June 17, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOROX CO /DE/
Report date December 31, 2025 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 13,610.3691 |
Reported balance
After 2025-02-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-02-14 · Grant · Acquired 111.336 · Balance 13,610.3691 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 13,733.5856 |
Reported balance
After 2025-05-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-05-09 · Grant · Acquired 123.2165 · Balance 13,733.5856 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 13,877.6604 |
Reported balance
After 2025-08-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-08-29 · Grant · Acquired 144.0748 · Balance 13,877.6604 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 14,039.5751 |
Reported balance
After 2025-11-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-11-06 · Grant · Acquired 161.9147 · Balance 14,039.5751 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 15,677.4328 |
Reported balance
After 2025-12-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-12-31 · Grant · Acquired 1,637.8577 · Balance 15,677.4328 F1: 1-for-1 F4: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
Filing footnotes · ownership attribution and instrument terms
F1: 1-for-1
F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.
METLIFE INC
Report date June 14, 2021 · Filed June 17, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 56,956 |
Reported balance
After 2021-06-14 transaction · row 1
1 source rowRow 1 · 2021-06-14 · Grant · Acquired 178 · Balance 56,956 F1: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the reporting person has deferred. |
Filing footnotes · ownership attribution and instrument terms
F1: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the reporting person has deferred.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2017 Filed Mar 2, 2017 21:47 UTC | METLIFE INC MET · Entity 488 | GrantRestricted Stock Units · Derivative | 4,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016699 · doc4.xml · derivative · entry 2 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,768 Underlying: Common Stock · 4,768 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · derivative.exercise_date: The Restricted Units vest in three equal installments on the first business day in March 2018, 2019 and 2020. F3 · derivative.expiration_date: The Restricted Units vest in three equal installments on the first business day in March 2018, 2019 and 2020. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:47 UTC | METLIFE INC MET · Entity 488 | GrantEmployee Stock Option (Right to Buy) · Derivative | 14,303 | $0.00 Strike: $52.44 | $0.00 |
DisclosureSEC source: 0001209191-17-016699 · doc4.xml · derivative · entry 1 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,303 Underlying: Common Stock · 14,303 shares Expires 2027-02-27 F1 · derivative.exercise_date: The options become exercisable in three equal installments on February 28, 2018, 2019, and 2020. Read SEC document |
| February 10, 2017 Filed Jan 3, 2018 23:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 24.2084 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-000439 · doc4.xml · derivative · entry 1 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,868.2074 Underlying: Common Stock · 24.2084 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 21:30 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,136.5522 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-000369 · doc4.xml · derivative · entry 5 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,843.999 Underlying: Common Stock · 1,136.5522 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 14, 2016 Filed Jan 4, 2017 21:30 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 19.0096 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-000369 · doc4.xml · derivative · entry 4 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,707.4468 Underlying: Common Stock · 19.0096 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 12, 2016 Filed Jan 4, 2017 21:30 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 16.0241 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-000369 · doc4.xml · derivative · entry 3 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,688.4372 Underlying: Common Stock · 16.0241 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 06, 2016 Filed Jan 4, 2017 21:30 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 15.6805 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-000369 · doc4.xml · derivative · entry 2 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,672.4131 Underlying: Common Stock · 15.6805 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 12, 2016 Filed Jan 4, 2017 21:30 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 15.9433 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-000369 · doc4.xml · derivative · entry 1 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,656.7326 Underlying: Common Stock · 15.9433 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.